Liver Fibrosis in HIV-Positive Patients With Hepatitis C Virus

Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Adriano Lazzarin(Vita-Salute San Raffaele University), Laura Galli(Vita-Salute San Raffaele University), Giovanni Sitia(Vita-Salute San Raffaele University), Caterina Sagnelli(University of Campania "Luigi Vanvitelli"), Giulia Gallotta(Vita-Salute San Raffaele University), Anna De Bona(Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo), Carlo Paties(Vita-Salute San Raffaele University)
JAIDS Journal of Acquired Immune Deficiency Syndromes
December 7, 2005
10.1097/01.qai.0000192001.15777.15
Cited by 39

Related Papers

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173
Discontinuation of Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy
|New England Journal of Medicine|2001|168